NT trends in ecstasy and related drug markets 2011 : findings from the Ecstasy and Related Drugs Reporting System (EDRS)
NT trends in ecstasy and related drug markets; Reports; PublicationNT
2011
Made available via the Publications (Legal Deposit) Act 2004 (NT).
Date:2011; Australian drug trends series No. 80
English
Drug abuse surveys -- Northern Territory -- Periodicals; Ecstasy (Drug) -- Northern Territory -- Periodicals; Drug abuse -- Northern Territory -- Periodicals
National Drug and Alcohol Research Centre, University of New South Wales
Sydney (N.S.W)
9780733430206
Check within Publication or with content Publisher.
https://hdl.handle.net/10070/242182
https://hdl.handle.net/10070/610318
vi List of Figures Figure 1: Age distribution of participants in the NT IDRS samples, 2002-2011 ......................... 6 Figure 2: Drug injected most last month, 2002-2011 ................................................................ 9 Figure 3: Patterns of heroin use by participants, 2002-2011................................................... 13 Figure 4: Proportion of participants reporting methamphetamine and pharmaceutical stimulant use in the past six months, 2002-2011 .................................................... 16 Figure 5: Patterns of methamphetamine use among recent users (any form), 2002-2011 ...... 16 Figure 6: Methamphetamine form most used in the preceding six months, among recent methamphetamine users, 2002-2011 ..................................................................... 17 Figure 7: Median days cocaine use in the past six months, 2003-2011 .................................. 18 Figure 8: Median number of days of cannabis use in the past six months, 2002-2011 ........... 19 Figure 9: Patterns of cannabis use by recent users, 2002-2011 ............................................. 20 Figure 10: Proportion of participants reporting ecstasy use and injection in the preceding six months, 2003-2011 ................................................................................................ 27 Figure 11: Patterns of ecstasy use, 2003-2011 ...................................................................... 27 Figure 12: Proportion of participants reporting hallucinogen use and injection in the preceding six months, 2003-2011 .......................................................................... 28 Figure 13: Median days use and injection of hallucinogens in the past six months, 2003-2011 .............................................................................................................. 28 Figure 14: Proportion of participants reporting benzodiazepine use and injection in the preceding six months, 2003-2011 .......................................................................... 29 Figure 15: Median days use and injection of benzodiazepines in the past six months, 2003-2011 .............................................................................................................. 29 Figure 16: Patterns of benzodiazepine use, 2003-2011 ......................................................... 30 Figure 17: Patterns of recent alcohol use, 2003-2011 ............................................................ 32 Figure 18: Participant reports of tobacco use in the last six months, 2003-2011 .................... 32 Figure 19: Participant reports of current heroin availability, 2001-2011 .................................. 35 Figure 20: Median prices of speed powder estimated from participant purchases, 2002-2011 .............................................................................................................. 39 Figure 21: Median prices of base estimated from participant purchases, 2002-2011.............. 39 Figure 22: Median prices of ice/crystal estimated from participant purchases, 2002-2011 ..... 39 Figure 23: Participant perceptions of methamphetamine purity (speed, base and ice/crystal) among those who commented, 2011 ..................................................................... 43 Figure 24: Proportion of participants reporting speed powder, base and ice/crystal purity as high, among those who commented, 2002-2011 .................................................. 43 Figure 25: Median prices of cannabis estimated from participant purchases, 2003-2011 ....... 46 Figure 26: Participant reports of current cannabis availability, 2002-2011 .............................. 47 Figure 27: Current potency of hydro, % able to comment, 2004-2011 .................................... 49 Figure 28: Current potency of bush, % commented, 2004-2011 ............................................. 49 Figure 29: Change in potency of hydro and bush cannabis in past six months, % able to comment, 2011 ...................................................................................................... 50 Figure 30: Current availability of illicit methadone, % commented, 2003-2011 ....................... 52 Figure 31: Change in availability of illicit methadone in the last six months, % commented, 2011 (n=5) ............................................................................................................. 53 Figure 32: Current availability of illicit Subutex, % commented, 2007-2011 ............................ 54 Figure 33: Change in availability of illicit Subutex/buprenorphine in the last six months, % commented, 2007-2011 ......................................................................................... 55 Figure 34: Current availability of illicit morphine, % commented, 2003-2011 .......................... 58 Figure 35: Change in availability of illicit morphine in the last six months, % commented, 2011 ....................................................................................................................... 58 Figure 36: Proportion of participants reporting treatment in the last six months, 2002-2011 ... 65 Figure 37: Number of episodes commenced in NT AODTS where heroin was the principal or other drug of concern, 2001/02-20010/11 .............................................................. 65